Leventhal describes the limits of current immunosuppression and the rationale behind early-phase clinical trials evaluating cellular therapies.
Joseph Leventhal, MD, PhD
Advertisement
Joseph Leventhal, MD, PhD, is a Professor of Surgery and Director of the Kidney and Pancreas Transplant Programs within the Comprehensive Transplant Center of the Northwestern University Feinberg School of Medicine.
Articles by Joseph Leventhal, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D
2
Orforglipron Delivers Significant Weight Loss At Every Stage of Menopause in Phase 3 ATTAIN Trials
3
What Comes Next for Berobenatide? VESPER-3 and Phase 3 Expectations, With John Buse, MD, PhD
4
ACHIEVE-5: Orforglipron Improves Glycemic Control, Weight in T2D on Basal Insulin
5